The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Sidorchuk M.A.

National Medical Research Center for Obstetrics, Gynecology and Perinatology named after academician V.I. Kulakov

Everything will be fine!

Authors:

Sidorchuk M.A.

More about the authors

Journal: Non Nocere. New Therapeutic Journal. 2026;(3): 28‑31

Read: 91 times

Buy for 300₽
Contact the author
Table of contents

To cite this article:

Sidorchuk MA. Everything will be fine! Non Nocere. New Therapeutic Journal. 2026;(3):28‑31. (In Russ.)

МСФ на ЯМ
Использование инфографики авторами научных работ
Abstract:

Prenatal diagnostics today: integrating DNA technologies (NIPS) into pregnancy management strategies.

Authors:

Sidorchuk M.A.

National Medical Research Center for Obstetrics, Gynecology and Perinatology named after academician V.I. Kulakov

Close metadata

References:

  1. Kagan KO, Sonek J, Wagner P, Hoopmann M. Principles of first trimester screening in the age of non-invasive prenatal diagnosis: screening for chromosomal abnormalities. Arch Gynecol Obstet. 2017 Oct;296(4):645-651.  https://doi.org/10.1007/s00404-017-4459-9
  2. Kagan KO, Etchegaray A, Zhou Y, Wright D, Nicolaides KH. Prospective validation of first-trimester combined screening for trisomy 21. Ultrasound Obstet Gynecol. 2009 Jul;34(1):14-18.  https://doi.org/10.1002/uog.6412
  3. Abedalthagafi M, Bawazeer S, Fawaz RI, Heritage AM, Alajaji NM, Faqeih E. Non-invasive prenatal testing: a revolutionary journey in prenatal testing. Front Med (Lausanne). 2023 Nov 9;10:1265090. https://doi.org/10.3389/fmed.2023.1265090
  4. Sukhikh G.T., Trofimov D.Yu., Barkov I.Yu., et al. Methodological recommendations “Noninvasive prenatal screening (NIPS) for fetal aneuploidies in maternal blood by high-throughput sequencing (NGS)”. Akusherstvo i Ginekologiya/Obstetrics and Gynecology. 2024; (3) (Supplement): 4-24. (In Russ.) https://doi.org/10.18565/aig.2024.51
  5. Tarasenko O.A., Vashukova E.S., Kozyulina P.Yu., et al. Experience of using high-throughput sequencing (NGS) for noninvasive prenatal screening of fetal aneuploidy at the D.O. Ott Research Institute of Obstetrics, Gynecology and Reproduction. Akusherstvo i Ginekologiya /Obstetrics and Gynecology. 2022; 10: 37-49. (In Russ.) https://doi.org/10.18565/aig.2022.10.37-49
  6. Luo W, He B, Han D, et al. A new contingent screening strategy increased detection rate of trisomy 21 in the first trimester. BMC Pregnancy Childbirth. 2023 Nov 14;23(1):791.  https://doi.org/10.1186/s12884-023-06115-1
  7. Kagan KO, Avgidou K, Molina FS, Gajewska K, Nicolaides KH. Relation between increased fetal nuchal translucency thickness and chromosomal defects. Obstet Gynecol. 2006 Jan;107(1):6-10.  https://doi.org/10.1097/01.AOG.0000191301.63871.c6
  8. Timmerman E, Pajkrt E, Maas SM, Bilardo CM. Enlarged nuchal translucency in chromosomally normal fetuses: strong association with orofacial clefts. Ultrasound Obstet Gynecol. 2010 Oct;36(4):427-432.  https://doi.org/10.1002/uog.7650
  9. Bardi F, Bosschieter P, Verheij J, et al. Is there still a role for nuchal translucency measurement in the changing paradigm of first trimester screening? Prenat Diagn. 2020 Jan;40(2):197-205.  https://doi.org/10.1002/pd.5590
  10. Salomon LJ, Alfirevic Z, Audibert F, et al. ISUOG Clinical Standards Committee. ISUOG consensus statement on the impact of non-invasive prenatal testing (NIPT) on prenatal ultrasound practice. Ultrasound Obstet Gynecol. 2014 Jul;44(1):122-123.  https://doi.org/10.1002/uog.13393
  11. Kalashnikova E.A., Glotov A.S., Andreyeva E.N., Barkov I.Y., Bobrovnik G.Y., Dubrovina E.V., Zhuchenko L.A. Current relevance of non-invasive prenatal study of cell-free fetal DNA in the mother’s blood and prospects for its application in mass screening of pregnant women in the Russian Federation. Journal of obstetrics and women’s diseases. 2021;70(1):19-50.  https://doi.org/10.17816/JOWD56573
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.